Veterinary Scientific Advice procedure - submission deadlines 2024

Withdrawn application: Bylvay, odevixibat, Date of withdrawal: 22/10/2023, Post-authorisation

Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders, Online, from 29/01/2024 to 29/01/2024

Referral: Topiramate, topiramate, Article 31 referrals, CMDh final position, 10/11/2023, 23/11/2023

Floseal haemostatic matrix (Floseal VH S/D) - Procedural steps and scientific information after initial consultation

Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Anxiety Disorders;Neuralgia;Epilepsy, Date of authorisation: 19/06/2015, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Zynrelef, bupivacaine,meloxicam, Pain, Postoperative, Date of authorisation: 24/09/2020, Revision: 3, Status: Withdrawn

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Heart Failure, Date of authorisation: 15/11/2023, Status: Authorised

Third Veterinary Big Data Stakeholder Forum, Amsterdam, from 23/11/2023 to 23/11/2023